Flublok Quadrivalent
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Flublok Quadrivalent, covering 2016-08-02 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of Age [Phase 1]